A. Oppenheim

A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11βHSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization

E. Keshet, Oren Gordon, Zhiheng He, 2014, PloS one.

Vascular Endothelial Growth Factor–Induced Neovascularization Rescues Cardiac Function But Not Adverse Remodeling at Advanced Ischemic Heart Disease

D. May, E. Keshet, Oren Gordon, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Cardiovascular Risk Factors and Physical Fitness Among Subjects with Asymptomatic Colonic Diverticulosis

E. Klang, U. Kopylov, S. Segev, 2022, Digestive Diseases and Sciences.

Erbin is a negative modulator of cardiac hypertrophy

Noa Dagan, R. Foo, J. Borg, 2014, Proceedings of the National Academy of Sciences.

A Novel Prediction Tool for Endoscopic Intervention in Patients with Acute Upper Gastro-Intestinal Bleeding

E. Klang, U. Kopylov, I. Levy, 2022, Journal of clinical medicine.

Immune Thrombocytopenia Caused by Fecal Microbial Transplantation in a Patient With Severe Recurrent Clostridium difficile Infection.

E. Melzer, S. Malnick, A. Oppenheim, 2015, Journal of clinical gastroenterology.

Disproportionately Low Albumin and High Neutrophil-to-Lymphocyte Ratio in Small Bowel Adenocarcinoma Patients With Long-Duration Crohn's Disease

U. Kopylov, S. Ben-Horin, T. Engel, 2022, Clinical and translational gastroenterology.

Monocyte Modulation by Liposomal Alendronate Improves Cardiac Healing in a Rat Model of Myocardial Infarction

G. Golomb, H. Danenberg, R. Efraim, 2019, Regenerative Engineering and Translational Medicine.